Search

everythinglearnresearchcommunity

for

Search:↓

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

A 6-year-old girl with Turner syndrome also had psoriasis, alopecia areata, and trachyonychia.

The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.

Lower BDNF levels link to worse depression in alopecia areata patients.

Trichoscopy helps correctly diagnose alopecia areata, not syphilitic alopecia, in patients with recent syphilis.

Histopathological confirmation is crucial for accurately diagnosing challenging alopecia areata cases.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Fractional CO2 laser is more effective and safer than steroid injections for treating alopecia areata.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

Recognizing and treating overlap syndrome in connective tissue diseases is crucial.

Homeopathic treatment might help manage alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

People with alopecia areata have a higher risk of stroke.

Alopecia areata involves immune response and gene changes affecting hair loss.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.